Research & Development

香蕉伊人影院手机在线观看香蕉伊人影院国产在线观看热热热色色原网站Facebook涉嫌诱骗儿童在平台上消费 美议员呼吁调…


  霍去病笑道︰“我大漢列侯豈是那些奴賊所能比擬的。”   衛皇後笑道︰“君侯盡管說。”香蕉伊人影院手机在线观看   劉據在擊敗滇國的慶功宴上多喝了幾杯酒,結果就上吐下瀉,高熱不退在狄山寫信的時候已經七天了,憔悴的不成人形,狄山希望能夠獲得皇帝恩準,允許劉據返回蜀中養病。香蕉伊人影院国产在线观看   沒道理允許曹襄從他這里剽竊無數,就不準許他抄襲一下敕勒族的歌?   在眾人齊聲喝彩中,曹襄酒到杯干,不大功夫就醉倒在臥虎石上。热热热色色原网站   狄山擦一把臉上的雨水道︰“已經……出發。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo